Free Trial

Connect Biopharma (CNTB) SEC Filings & 10K Form

Connect Biopharma logo
$1.13 -0.01 (-0.45%)
As of 07/8/2025 03:31 PM Eastern

Recent Connect Biopharma SEC Filings

DateFilerForm TypeView
06/26/2025
11:15 PM
Connect Biopharma (Filer)
Form EFFECT
06/11/2025
7:02 AM
Connect Biopharma (Subject)
Wei Zheng (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2025
3:35 PM
Connect Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/14/2025
8:10 AM
Connect Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
8:10 AM
Connect Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
8:04 AM
Connect Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
8:02 AM
Connect Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
8:04 AM
Connect Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/23/2024
3:05 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
4:01 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2024
3:20 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CNTB) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners